论文部分内容阅读
目的观察舒利迭吸入治疗慢性阻塞性肺疾病的疗效。方法随机选取慢性阻塞性肺疾病136例分为对照组和观察组,对照组给予阻塞性肺疾病常规治疗,观察组在常规治疗基础上给予舒利迭吸入。结果观察组总有效率明显优于对照组,差异有统计学意义(P<0.05);PaO2、PEF、DDI指标显示,应用舒利迭时,远期疗效优近期疗效。结论舒利迭吸入治疗慢性阻塞性肺疾病疗效显著,不良反应少。
Objective To observe the efficacy of seretide inhalation in the treatment of chronic obstructive pulmonary disease. Methods 136 cases of chronic obstructive pulmonary disease were randomly divided into control group and observation group. The control group was given routine treatment of obstructive pulmonary disease. The observation group was given inhaled seretide on the basis of routine treatment. Results The total effective rate of the observation group was significantly better than that of the control group, the difference was statistically significant (P <0.05); PaO2, PEF, DDI indicators show that when using Seretide, long-term efficacy superior effect. Conclusion Seretide inhalation in the treatment of chronic obstructive pulmonary disease has obvious curative effect and few adverse reactions.